Quotes Processa Pharmaceuticals, Inc. OTC Markets
Stocks
PCSA
US74275C4033
Biotechnology & Medical Research
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 6.100 USD | -38.38% |
|
-.--% | - |
| 07-29 | Processa Pharmaceuticals, Inc. acquired Vidya Therapeutics, Inc. for approximately $320 million. | CI |
| 07-29 | Processa Pharmaceuticals, Inc. - M&A Call |
Performance
| 1 day | -38.38% |
Volumes
marketsDaily volume
11,680
Estimated daily volume
11,680
Record volume 1
0
Record volume 2
0
Record volume 3
0
Capital turnover ratio
0
Float rotation
0
Basic data
Market Cap (USD)
8,443,031
Net sales (USD)
-
Number of employees
12
Sales / Employee ()
0
Sales / Employee (USD)
0
Free-Float
85.1 %
Free-Float capitalization (USD)
7,231,557
Indicators
RSI 9 days
0
RSI 14 days
0
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -38.38% | -.--% | - | - | 8.44M | |
| +0.47% | +2.27% | +50.78% | +70.84% | 55.01B | |
| +2.83% | +0.48% | +28.18% | +82.59% | 54.24B | |
| +0.54% | +1.22% | -16.62% | -13.47% | 23.38B | |
| -0.97% | -3.30% | -1.79% | +383.00% | 22.57B | |
| -4.06% | -2.45% | +14.61% | -13.20% | 20.19B | |
| -2.15% | -2.30% | +27.27% | -31.03% | 17.86B | |
| -2.97% | -6.65% | +25.27% | +544.34% | 15.5B | |
| -2.09% | +0.64% | +49.78% | +178.74% | 14.2B | |
| -3.14% | -8.47% | +165.37% | +292.18% | 14.2B | |
| Average | -4.79% | -0.56% | +38.09% | +166.00% | 23.72B | |
| Weighted average by Cap. | -0.14% | -0.11% | +34.25% | +130.76% |
Historical Quotes: Processa Pharmaceuticals, Inc.
| Date | Opening | High | Low | Close | Volume | Change |
|---|
Monthly variations
- Stock Market
- Stocks
- PCSA Stock
- PCSA Stock
- Quotes Processa Pharmaceuticals, Inc.
Select your edition
All financial news and data tailored to specific country editions
